98%
921
2 minutes
20
Objectives: Familial Mediterranean Fever (FMF) is a hereditary auto-inflammatory disorder that is caused by mutations in the Mediterranean fever (MEFV) gene and is associated with an increase in pro-inflammatory cytokines, such as interleukin-1β (IL-1β) and interleukin-18 (IL-18), leading to excess inflammation. Colchicine is a common drug widely used for treatment of FMF attacks, but about 5-15% of the patients show resistance to the regular colchicine treatment. In this study, we used dimethylamino-parthenolide (DMAPT), as a small molecule inhibitor of Nuclear factor-κB (NF-κB), NLR family Pyrin domain containing 3 (NLRP3), and cysteine-aspartic acid protease 1(Caspase-1) on FMF-derived peripheral blood mononuclear cells (PBMCs).
Materials And Methods: The effects of DMAPT and colchicine on metabolic activity and apoptosis of FMF-derived PBMCs were evaluated by MTT and Annexin V/PI assays, respectively. Also, the expression levels of NF-κB, NLRP3, MEFV, CASP1, and IL-1β mRNA were investigated using a TaqMan real-time PCR, and the protein levels of IL-1β, IL-18, and IL-37 were assessed via an enzyme-linked immunosorbent assay (ELISA) in LPS/ ATP-stimulated PBMCs.
Results: DMAPT decreased the expression levels of NFκB (0.38±0.096, 0.0001), NLRP3 (0.39±0.12, 0.001), MEFV (0.384±0.145, 0.001), CASP1 (0.48±0.13, 0.0023), and IL-1β (0.09±0.09, 0.0001) and reduced the secretion levels of IL-1β (8.92±5.3 vs. 149.85±20.92, 0.0001), IL-18 (135±32.1 vs. 192±22.18, 0.01), and IL-37 (27.5±6.3 vs. 78.19±14.3, 0.0001) as compared to untreated cells.
Conclusion: Given the obtained results in comparison with previous research, the future clinical development of DMAPT could result in the expansion of new anti-inflammatory therapeutics for FMF disorder.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769508 | PMC |
http://dx.doi.org/10.22038/IJBMS.2021.59180.13140 | DOI Listing |
Int J Infect Dis
September 2025
Servicio de Brucellosis, Hospital F. J. Muñiz, 1282 Buenos Aires, Argentina.
Objectives: Brucellosis remains a significant zoonotic disease in endemic regions, with relapse and focal complications posing significant clinical challenges. This study aimed to identify risk factors associated with brucellosis relapse and focal disease in North Khorasan, Iran, over a nine-year period.
Methods: A retrospective analysis was conducted on 2,568 confirmed brucellosis cases from 2015 to 2024, using data from multiple centers.
Rheumatol Int
September 2025
Division of Perinatology, Department of Obstetrics, Zeynep Kamil Women and Children's Diseases Training and Research Hospital, Istanbul, Turkey.
Familial Mediterranean Fever (FMF) is frequently diagnosed during reproductive ages, but its impact on pregnancy remains unclear. We aimed to evaluate maternal and neonatal outcomes in FMF pregnancies by comparing before and after diagnosis periods as well as with healthy controls, and to identify predictors of adverse outcomes. This retrospective, cross-sectional study included 215 pregnancies (129 before and 86 after FMF diagnosis) from 81 women with FMF and 94 pregnancies from 42 healthy controls.
View Article and Find Full Text PDFFront Neurosci
August 2025
Department of Neurology, National Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
Background: Brucellosis, a zoonotic disease caused by species, remains endemic in regions such as Saudi Arabia. While neurobrucellosis is a serious complication, its presentation with parkinsonian features and psychiatric manifestations is exceedingly rare, with only five such cases reported in the literature. These case reports add to the limited data on atypical presentations of neurobrucellosis.
View Article and Find Full Text PDFBMJ Case Rep
September 2025
Surgical, Nottingham University Hospitals NHS Trust-City Campus, Nottingham, Nottinghamshire, UK.
Familial Mediterranean fever (FMF) is an autosomal recessive auto-inflammatory disorder that primarily affects individuals of Mediterranean, Middle Eastern and South Asian origin . We report the case of a male patient in his late 20s who was diagnosed with FMF at the age of 17 years. Prior to the diagnosis, he underwent two unnecessary surgical interventions due to recurrent episodes of acute abdominal pain-an appendectomy, followed 3 years later by a negative exploratory laparotomy for suspected adhesive small bowel obstruction (SBO).
View Article and Find Full Text PDFSemin Arthritis Rheum
August 2025
Rheumatology Unit, Sheba Medical Center, Tel Hashomer. Ramat Gan, 52621, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, P.O.B 39040. Ramat Aviv, Tel Aviv 69978, Israel; Department of Medicine F, Sheba Medical Center, Tel Hashomer. Ramat Gan, 52621, Israel. Electronic addre
Objectives: The homozygous M694V genotype is associated with the most severe form of familial Mediterranean fever (FMF). This study aims to explore whether this genotype is linked not only to classical FMF features, but also to additional, non-canonical manifestations.
Methods: A hypothesis-generating study was conducted using an automated algorithm to extract data from structured medical records of patients followed at the FMF clinic of Sheba Medical Center between 2010 and 2020.